Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2‐year prospective study

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-1241|69|S183|43-52

ISSN： 1368-5031

Source： INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol.69, Iss.S183, 2015-05, pp. : 43-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1843-1854

John Wiley & Sons Inc

Access to resources Recommend Favorite

Kidney Transplant Recipients Carrying the CYP3A4*22 Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 3, 2015-03 ,pp. : 800-805

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. S183, 2015-05 ,pp. : 16-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients

By                        

International Journal of Molecular Medicine, Vol. 28, Iss. 6, 2011-01 ,pp. : 1093-1102

Spandidos Publications

Access to resources Recommend Favorite